Stock Rockstar
10年前
CDXI has former CFO of Novartis, wow!!
$CDXI Offers Alternative to Tylenol, Secures Major Partnerships
(NEW YORK)--Cardax, Inc. (OTC:CDXI), a development stage, life sciences company focused on introducing nutraceutical and pharmaceutical products aimed at reducing inflammation and oxidative stress, closes major agreements to develop new anti-inflammatory products.
Alternative to Acetaminophen (Tylenol)
As many have become aware over the past few years, the use of popular over-the-counter pain relievers containing acetaminophen, such as with Tylenol and other name brand pain relievers, has shown to cause liver damage from overuse, especially people prone to liver issues.
An example, if you did not know, it is highly recommended you don't take acetaminophen products to treat a hangover as the effects of the acetaminophen, and the bodies processing of the alcohol, has shown to cause extreme stress on the liver, and under prolonged use can cause permanent damage.
In addition, there are also issues with people with standing liver disease (unrelated to alcohol) who also can not benefit from the effects of acetaminophen as an over-the-counter pain reliever. This sets up a multi-billion dollar market for alternatives to this popular over-the-counter medicine, and CDXI has that with astaxanthin.
Experienced Board of Directors
If you want to get a good idea on why CDXI stands out from most other penny stocks, then take a look at just a sample of who sits on their Board of Directors.
Mr. George Bickerstaff held various positions with Novartis International AG, a global pharmaceuticals and consumer health company, including Chief Financial Officer of Novartis Pharma AG from October 2000 to May 2005. Ms. Tamar Howson served as Senior Vice President, Corporate and Business Development at Bristol-Myers Squibb from 2001 to 2007.
Mr. Bickerstaff and Ms. Howson, are both currently members of the Board of Directors with CDXI.
Major Partnership Agreements
CDXI recently closed partnership deals with BASF and Capsugel to develop and bring new anti-inflammatory products to market, and commercialization under revenue sharing agreements.
BASF, the world's largest chemical company, has licensed exclusive rights from CDXI for the commercialization of nature-identical, synthetic astaxanthin, ASTX-1, as a nutraceutical. With lower regulatory restrictions on nutraceuticals, the product approval and introduction should move much faster than a pharmaceutical drug, allowing BASF and CDXI to have a product available for sale in 2015.
Add together CDXI experienced Board with years of history in major pharmaceutical companies, their partnership agreements with major drug developers, and a product that provides an alternative to popular over-the-counter drugs, such as Tylenol, and CDXI may be one of those few "real deal" companies not normally found on the OTC exchange.
sweet crude
10年前
Also Bristol-Myers Squibb???
Tamar D. Howson , age 65, will serve as a director of the Company commencing June 16, 2014. She has served as an independent corporate business development and strategy consultant to life science companies since 2011. From 2009 to 2011, she provided business development support to life sciences companies as a member of the transaction team at JSB-Partners. From 2007 to 2008, Ms. Howson served as Executive Vice President, Corporate Business Development at Lexicon Pharmaceuticals. From 2001 to 2007, Ms. Howson served as Senior Vice President, Corporate and Business Development at Bristol-Myers Squibb.
sweet crude
10年前
former CFO of Novartis on CDXI board...wow!
George W. Bickerstaff, III , age 59, will serve as a director of the Company commencing June 16, 2014. Mr. Bickerstaff is currently a Managing Director of M.M. Dillon & Co., LLC, which he joined in 2005. Prior to joining M.M. Dillon & Co., LLC, Mr. Bickerstaff held various positions with Novartis International AG, a global pharmaceuticals and consumer health company, including Chief Financial Officer of Novartis Pharma AG from October 2000 to May 2005.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10053109
That's major!
Big Brother
12年前
Yeah your probably right, just looks like a small coffee shop in downtown Houston that wants to raise the capital to open a couple new locations.
Wouldn't surprise me to see a stock promotion here someday.
http://www.koffeekornerinc.com/
Company Description
KOFFEE KORNER INC. (“Koffee Korner”, “we”, “us” or the “Company”) was initially
formed as a Texas Corporation in July 2003 and became a Delaware corporation in
February 2012.
Koffee Korner is a single location retailer of specialty coffee located on the
2 nd floor mezzanine level of a high rise
building in Houston, Texas. Koffee
Korner purchases its coffee, food, tea and restaurant supplies from its
principle supplier SYSCO and sells rich-brewed coffees, Italian-style espresso
beverages, cold blended beverages, and complementary food items which include
bakery items, sandwiches prepared by our staff, fruit and yogurt, a selection
of teas, and beverage-related accessories and equipment, prepared by our staff
and sold through our retail location. 85% of our sales are coffee sales (which
include brewed coffees, Italian-style espresso beverages and cold blended
beverages), 10% of our sales are food items (which include bakery items,
sandwiches prepared by our staff, fruit and yogurt), and 5% are teas and
beverage-related accessories and equipment. Occasionally, we run out of an item
and purchase small amounts of that item locally to tide us over until our next
delivery from SYSCO. The majority of our customers come from the tenants in our
building. We do get some foot traffic as we are in downtown Houston. We
estimate that 90% of our business is generated by the tenants of our building
and 10% of our business is generated by foot traffic. We estimate 85% of our
customers consume our products via takeaway and 15% of our customers consume
our products on our premises. We had revenues of $72,692 and a loss of
$(9,735) during our fiscal year ended March 31, 2012. We had revenues of
$16,917 and a loss of $(1,820) during the quarter ended June 30, 2012.
Given our recent rate of negative cash flow in our operations, which is
approximately $600 per month, as well as the likelihood that our cash burn rate
will increase once we become a reporting company due to increased accounting,
audit, attorney, and EDGAR professional fees of approximately $5,000 per
quarter, we believe that unless gross profits increase we do not have
sufficient capital to carry on operations past June of 2013, but we plan to
raise additional capital in a Regulation D Rule 505 exemption private placement
equity offering six months after the effective date of this prospectus, or if
current proposed regulations are adopted, three months from the date of this
prospectus, to secure the funds needed to finance our plan of operation for
fiscal year 2013 and overcome the uncertainty of our ability to continue as a
going concern. This $50,000 raise would allow us to continue for approximately
24 months past June 2013 at the current burn rate. However, this is a forward-
looking statement, and there may be changes that could consume available
resources before such time. Our contingency plan if the funds cannot be raised
is to; 1) have the company seek a bank credit line; 2) receive loans from our
officers; 3) private equity investments or debt financing from individuals or
entities. Our long term capital requirements and the adequacy of our available
funds will depend on many factors, including the eventual reporting company
costs and public relations fees, among others. If we are unable to raise
additional capital or generate sufficient revenue we will have to curtail or
cease our operations.
The Company’s objective is to obtain the resources to open an additional three
new locations in the Houston, Texas metropolitan area during the next two to
three years. However, there can be no assurance that we will ever open any
additional locations. Management estimates that the cost of establishing
additional retail locations will be approximately $250,000 per location.
Management hopes to be in a position to open additional locations in the next
24 to 36 months. In order to be able to obtain the resources to open additional
locations, management will need to raise money, find suitable locations and
suitable personnel to run the new locations. We have had early stage
discussions with investors about potential investment in our firm at a future
date. No assurance can be made that such financing would be available, and if
available it may take either the form of debt or equity. In either case, the
financing could have a negative impact on our financial condition and our
shareholders. We have no commitments for any financing and cannot assure you
that we will realize this goal.
-----
Koffee Korner Inc.
6560 Fannin St., Suite 245
Houston, TX 77030-2728
Telephone no : (713) 795-0011
Our website : www.KoffeeKornerInc.com.
Read more: www.nasdaq.com/markets/ipos/company/koffee-korner-inc-882850-70008#ixzz2cbmdccVJ
Hot Features
プレミアム
登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Renee
5年前
willlbone
6年前
spoom
7年前
stocktrademan
9年前
PeaceMaker
9年前
